Both in Pharmaceuticals
Tilray Brands vs Gyre Therapeutics
Over the past year TLRY returned −76.1% and GYRE returned −38.8%; their daily moves had a correlation of 0.14.
TLRY −76.1% GYRE −38.8%Growth of $1, one year, split-adjusted
| Metric | TLRY | GYRE |
|---|---|---|
| Price | $2.96 | $4.44 |
| Market cap | $437.5M | $470.8M |
| Today | +11.70% | 0.00% |
| 1 month | −21.7% | −37.3% |
| 6 months | −48.6% | −44.8% |
| Year to date | −67.2% | −37.1% |
| 1 year | −77.4% | −39.7% |
| Revenue growth (YoY) | +22.7% | −2.1% |
| Gross margin | 30.1% | 92.4% |
| Net margin | −16.8% | −40.1% |
| P/E (TTM) | — | — |
| Price / sales | 0.5× | 3.9× |
| Net cash | $16.6M | $74.8M |
| Dividend yield | — | — |
| Volatility (60d) | 50.2% | 88.3% |
| Short % of float | 14.6% | 11.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).